Granules India Outlines Long-Term Growth Engines and ₹2,000 Crore Expansion Plan
Granules India Ltd · Transcript · 06 Oct 2026, 11:00 pm
Granules India Outlines Long-Term Growth Engines and ₹2,000 Crore Expansion Plan Granules India plans to invest ₹2,000 crore in organic capex over the next 3–4 years, targeting complex generics, oncology, US operations, and peptide CDMO. Peptide CDMO entity Senn Tides targets $50m revenue in three years and over $100m in five years. Complex generics contribution reached 33% of FY26 revenue, supported by a strong first-to-file pipeline. R&D spending expanded to 6% of revenue in Q1 FY27, while ROCE rose YoY to 18%. Warrants proceeds received in Sep'26 elevated the company to a consolidated net cash position.
Original exchange filing (PDF)
More announcements from Granules India Ltd
- Schedule of Investor Meet · 11 Nov 2026
- Change in Corporate Office Address of Registrar and Share Transfer Agent (RTA) · 06 Nov 2026
- Transcript of the Earnings Conference Call for Q2 and the half year of FY27 · 06 Nov 2026
- Audio recording of the Earnings Conference call for Q2 and the half -year of FY27 · 03 Nov 2026
- Monitoring Agency Report for the quarter ended on September 30, 2026 · 02 Nov 2026
- Investor Presentation to Analysts/Investors · 02 Nov 2026
- Press Release · 02 Nov 2026
- Unaudited financial results for the second quarter and half year ended on September 30,2026 · 02 Nov 2026
